Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator — Class II drug recall D-1324-2022
Terminated recall by Mckesson Medical-Surgical Inc. Corporate Office, reported 2022-08-17, distributed nationwide. CGMP Deviations: products were stored outside the drug label specifications.
| Recall number | D-1324-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA, United States |
| Recall initiated | 2022-06-29 |
| Classified | 2022-08-05 |
| Reported by FDA | 2022-08-17 |
| Terminated | 2024-02-13 |
| Distributed | Nationwide (US) |
| Quantity | 1 boxes |
| Reason classes | labeling, cgmp |
| NDC | 00487-2784-01 |
Product
Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.
Reason for recall
CGMP Deviations: products were stored outside the drug label specifications.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1324-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.